DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
« Back to Dashboard
Abemaciclibis the generic ingredient in one branded drug marketed by Eli Lilly And Co and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.
Abemaciclib has fifty patent family members in forty-four countries.
One supplier is listed for this compound.
Summary for abemaciclib
|Finished Product Suppliers / Packagers:||1|
|Raw Ingredient (Bulk) Api Vendors:||70|
|What excipients (inactive ingredients) are in abemaciclib?||abemaciclib excipients list|
|DailyMed Link:||abemaciclib at DailyMed|
Recent Clinical Trials for abemaciclib
Identify potential brand extensions & 505(b)(2) entrants
|Sarcoma Alliance for Research through Collaboration||Phase 3|
|H. Lee Moffitt Cancer Center and Research Institute||Phase 1/Phase 2|
|Genentech, Inc.||Phase 2|
Pharmacology for abemaciclib
|Drug Class||Kinase Inhibitor |
|Mechanism of Action||Kinase Inhibitors |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Eli Lilly And Co||VERZENIO||abemaciclib||TABLET;ORAL||208716-002||Sep 28, 2017||RX||Yes||No||⤷ Free Forever Trial||⤷ Free Forever Trial||⤷ Free Forever Trial|
|Eli Lilly And Co||VERZENIO||abemaciclib||TABLET;ORAL||208716-003||Sep 28, 2017||RX||Yes||No||⤷ Free Forever Trial||⤷ Free Forever Trial||⤷ Free Forever Trial|
|Eli Lilly And Co||VERZENIO||abemaciclib||TABLET;ORAL||208716-001||Sep 28, 2017||RX||Yes||No||⤷ Free Forever Trial||⤷ Free Forever Trial||⤷ Free Forever Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
|Patent Number||Supplementary Protection Certificate||SPC Country||SPC Expiration||SPC Description|
|2379528||2019009||Norway||⤷ Free Forever Trial||PRODUCT NAME: ABEMACIKLIB ELLER FARMASOEYTISK AKSEPTABLE SALTER DERAV; REG. NO/DATE: EU/1/18/1307 20180927|
|2379528||19C1008||France||⤷ Free Forever Trial||PRODUCT NAME: ABEMACICLIB; REGISTRATION NO/DATE: EU/1/18/1307 20181001|
|2379528||132019000000037||Italy||⤷ Free Forever Trial||PRODUCT NAME: ABEMACICLIB(VERZENIOS); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/18/1307, 20181001|
|>Patent Number||>Supplementary Protection Certificate||>SPC Country||>SPC Expiration||>SPC Description|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.